GKOS saw its Momentum Indicator move above the 0 level on December 16, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where GKOS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for GKOS just turned positive on December 17, 2024. Looking at past instances where GKOS's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 305 cases where GKOS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GKOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.970) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (14.327) is also within normal values, averaging (43.338).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
an ophthalmic medical device company
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
APLY | 18.65 | 0.12 | +0.65% |
YieldMax AAPL Option Income Strategy ETF | |||
BKAG | 41.73 | 0.01 | +0.02% |
BNY Mellon Core Bond ETF | |||
IQSU | 50.54 | -0.08 | -0.17% |
NYLI Candriam U.S. Large Cap Equity ETF | |||
NZUS | 32.96 | -0.08 | -0.24% |
SPDR MSCI USA Climate Paris Aligned ETF | |||
GBUY | 36.64 | -0.25 | -0.67% |
Goldman Sachs Future Consumer Equity ETF |
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ALGN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ALGN could also see price increases.
Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
---|---|---|---|---|
GKOS | 100% | +1.54% | ||
ALGN - GKOS | 44% Loosely correlated | -0.56% | ||
ICUI - GKOS | 43% Loosely correlated | -1.19% | ||
BLFS - GKOS | 39% Loosely correlated | -1.83% | ||
PRCT - GKOS | 39% Loosely correlated | -0.96% | ||
IRMD - GKOS | 38% Loosely correlated | -0.34% | ||
More |